GHRS NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

GH Research PLC · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 28.07 USD
2.9% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 42.3% above the Trend Line and sits at 85.1% of its 52-week range. The latest completed week returned 2.9%, after a 3.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 55/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: earnings are due in 4d.

Setup score 68 out of 100
Latest Close 28.07 USD 31 Jul 2026
1W Return 2.9% latest completed week
4W Return 3.9% short-term follow-through
12W Return 31.0% quarterly tape
Trend Breadth 90.4% 47 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 17-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 7 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.9% Latest completed week; four-week move 3.9%. Indicator stack 95/74 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 55/100 conviction; expected move 13.6%. News sentiment 57/100 53 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 42.3% above the Trend Line and sits at 85.1% of its 52-week range. The latest completed week returned 2.9%, after a 3.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9112-week average 0.75

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.91Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers77 reversal markers

No recent accumulation markers. 7 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.9% over four weeks, 31.0% over 12 weeks, and 104.3% over one year. The current trend has remained active for 17 consecutive weeks.

Performance by holding period

1W2.9%
4W3.9%
12W31.0%
26W79.2%
52W104.3%
Active trend streak17 weeks
Active weeks in one year47
Trend breadth90.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.30Latest activity-pressure read.
Pressure change7.5%Four-week change in activity pressure.
Leadership52.94Latest relative-leadership reading.
RS change12.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength60/100Blend of value, momentum, and quality. Underlying universe rank 41; rank 1 is best.
Value54/100Relative valuation strength. Underlying universe rank 47; rank 1 is best.
Quality53/100Profitability and accounting quality. Underlying universe rank 48; rank 1 is best.
Momentum54/100Medium-term price momentum. Underlying universe rank 47; rank 1 is best.
Growth55/100Revenue and earnings growth. Underlying universe rank 46; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-2.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-208.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
-0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
4.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

GHRS shows volatility options pressure with a 55/100 conviction score, put-call volume ratio of 0.00, expected move of 13.6%, and Sharemaestro trend signal active.

Conviction55/100
Expected move13.6%
Put/call volume0.00
Pressure88
Speculation11
Volatility89
Trend agreement26
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment57/100

Weighted news tone is neutral across 53 relevant articles.

17 positive · 35 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move13.6%Nearest-chain priced movement where available.
52-week drawdown-9.5%Distance below the 52-week high.
13-week volatility8.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+26.9%Week of 26 Jun.
Worst week-10.7%Week of 5 Jun.
Latest week+2.9%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains4
Flat weeks0
Modest losses5
Sharp losses7
Recent vol8.7%13-week weekly-return volatility.
Base vol7.8%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew7.2% / -5.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape68/100

Trend, activity pressure, participation, and risk combine to a 68/100 tape read.

 Indicator analysis82/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.91; 7 reversal markers Factors54/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 68; Small Cap Core rank 51 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options44/100

GHRS shows volatility options pressure with a 55/100 conviction score, put-call volume ratio of 0.00, expected move of 13.6%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 13.6% Sentiment57/100

Weighted news tone is neutral across 53 relevant articles.

(GHRS) Volatility Zones as Tactical Triggers Insiders50/100

No recent insider transaction evidence is stored.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202628.07 USD2.9%19.73 USD12.31 USD1.3052.941.3MOn
24 Jul 202627.28 USD-5.0%19.23 USD12.21 USD1.4151.19813.4KOn
17 Jul 202628.71 USD8.3%18.74 USD12.13 USD1.6058.212.6MOn
10 Jul 202626.51 USD-1.9%18.22 USD12.03 USD1.3941.031.1MOn
3 Jul 202627.01 USD-4.3%17.77 USD11.94 USD1.2147.15796.5KOn
26 Jun 202628.22 USD26.9%17.36 USD11.85 USD1.1256.351.7MOn
19 Jun 202622.24 USD5.3%16.93 USD11.74 USD1.0919.211.0MOn
12 Jun 202621.12 USD-1.4%16.66 USD11.68 USD1.2916.821.2MOn
5 Jun 202621.43 USD-10.7%16.42 USD11.62 USD1.4721.741.4MOn
29 May 202623.99 USD8.5%16.15 USD11.56 USD1.5930.821.0MOn
22 May 202622.12 USD3.4%15.83 USD11.48 USD1.5825.011.7MOn
15 May 202621.39 USD-0.1%15.56 USD11.41 USD1.5323.20685.7KOn
8 May 202621.42 USD3.4%15.30 USD11.34 USD1.2923.851.1MOn
1 May 202620.71 USD2.3%15.00 USD11.27 USD0.8327.21900.6KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.